Bringing the fundamentals into focus…
Back to Lyell Immunopharma, Inc.
How Lyell Immunopharma, Inc. stacks up
LYEL · against 1,216 other Healthcare companies
Growth
5/ 100
Near the bottom of its peers.
Ranked #1,151 of 1,217 · scores higher than 5% of peers
Bars: peers in each 10-point band of the growth score116 peers with a growth score of 0–9, including LYEL · Click a bar to see the companies
Why growth scores 5?
Weighted metrics compared with all Healthcare companies.Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over three years: weaker than 100% of peers. 3-year revenue growth: -91.8% vs peer median 5.8%
- slower revenue growth over the last year: weaker than 96% of peers. Revenue growth: -55.0% vs peer median 6.1%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = LYEL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LYEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -55.0% | 6.1% | 4% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -91.8% | 5.8% | 0% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around LYEL| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1,151 | 551M USD | 5 | 20 | |
| 1,151 | 4.8B USD | 5 | 27 | |
| 1,151 | 4.6B USD | 5 | 29 | |
| 1,151 | 952M USD | 5 | 3 | |
| 1,151 | 264M USD | 5 | 24 | |
| 1,151 | 91.2B USD | 5 | 18 | |
| 1,151 | 26.0B USD | 5 | 28 | |
| 1,163 | 429M HKD (≈$55M) | 4 | 20 | |
| 1,163 | 3.6B CNY (≈$506M) | 4 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score